Literature DB >> 2271015

Experimental autoimmune hepatitis: disease induction, time course and T-cell reactivity.

A W Lohse1, M Manns, H P Dienes, K H Meyer zum Büschenfelde, I R Cohen.   

Abstract

This study describes a murine model of autoimmune hepatitis: experimental autoimmune hepatitis. Experimental autoimmune hepatitis could be induced most effectively in male C57BL/6 mice by intraperitoneal immunization with the 100,000 g supernatant of syngeneic liver homogenate (S-100) in complete Freund's adjuvant. BALB/C and C3H mice were less susceptible than C57BL/6 mice. Experimental autoimmune hepatitis could not be induced in Lewis rats. Intraperitoneal immunization was more effective than intramuscular or subcutaneous injections, and the amount of protein administered above a threshold was of little influence. A single intraperitoneal injection of S-100 in complete Freund's adjuvant resulted in hepatitis of at least 6 mo duration. Histological changes were most marked 4 wk after disease induction. The histological findings were characterized mainly by perivascular inflammatory infiltrates and hepatocyte necroses. The histological changes were accompanied by biochemical evidence of liver cell death. Passive transfer of experimental autoimmune hepatitis with concanavalin A-activated splenocytes was possible. Specific T-cell reactivity against fractions of S-100 could be demonstrated in vitro. Thus experimental autoimmune hepatitis is a murine model of autoimmune hepatitis probably mediated by autoreactive T cells. It will allow studies of the pathogenesis of autoimmune hepatitis.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2271015     DOI: 10.1002/hep.1840110106

Source DB:  PubMed          Journal:  Hepatology        ISSN: 0270-9139            Impact factor:   17.425


  25 in total

Review 1.  Immune mechanisms of Concanavalin A model of autoimmune hepatitis.

Authors:  Hai-Xia Wang; Man Liu; Shun-Yan Weng; Jing-Jing Li; Chao Xie; Hong-Lin He; Wen Guan; Yun-Sheng Yuan; Jin Gao
Journal:  World J Gastroenterol       Date:  2012-01-14       Impact factor: 5.742

2.  Autoimmune hepatitis induced by syngeneic liver cytosolic proteins biotransformed by alcohol metabolites.

Authors:  Geoffrey M Thiele; Michael J Duryee; Monte S Willis; Dean J Tuma; Stanley J Radio; Carlos D Hunter; Courtney S Schaffert; Lynell W Klassen
Journal:  Alcohol Clin Exp Res       Date:  2010-09-22       Impact factor: 3.455

Review 3.  Chronic active hepatitis.

Authors:  P J Johnson; I G McFarlane
Journal:  Gut       Date:  1991-09       Impact factor: 23.059

4.  Centrilobular necrosis in autoimmune hepatitis: a histological feature associated with acute clinical presentation.

Authors:  H Hofer; C Oesterreicher; F Wrba; P Ferenci; E Penner
Journal:  J Clin Pathol       Date:  2006-03       Impact factor: 3.411

5.  Remission of experimental autoimmune hepatitis is associated with antigen-specific and non-specific immunosuppression.

Authors:  A W Lohse; K H Meyer zum Büschenfelde
Journal:  Clin Exp Immunol       Date:  1993-10       Impact factor: 4.330

Review 6.  Hepatitis mouse models: from acute-to-chronic autoimmune hepatitis.

Authors:  Muhammed Yüksel; Debby Laukens; Femke Heindryckx; Hans Van Vlierberghe; Anja Geerts; F Susan Wong; Li Wen; Isabelle Colle
Journal:  Int J Exp Pathol       Date:  2014-08-12       Impact factor: 1.925

7.  Liver tissue metabolically transformed by alcohol induces immune recognition of liver self-proteins but not in vivo inflammation.

Authors:  Michael J Duryee; Benjamin M Wiese; Jordan R Bowman; Jared D Vanlandingham; Lynell W Klassen; Geoffrey E Thiele; Carlos D Hunter; Daniel R Anderson; Ted R Mikuls; Geoffrey M Thiele
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2017-12-28       Impact factor: 4.052

Review 8.  Autoimmune hepatitis. Definition--classification--histopathology--immunopathogenesis.

Authors:  K H Meyer zum Büschenfelde; H P Dienes
Journal:  Virchows Arch       Date:  1996-09       Impact factor: 4.064

9.  Suppressive and pro-inflammatory roles for IL-4 in the pathogenesis of experimental drug-induced liver injury.

Authors:  Dolores B Njoku; Zhaoxia Li; Nicole D Washington; Jenelle L Mellerson; Monica V Talor; Rajni Sharma; Noel R Rose
Journal:  Eur J Immunol       Date:  2009-06       Impact factor: 5.532

Review 10.  Review on Toll-Like Receptor Activation in Myasthenia Gravis: Application to the Development of New Experimental Models.

Authors:  Marieke Robinet; Solène Maillard; Mélanie A Cron; Sonia Berrih-Aknin; Rozen Le Panse
Journal:  Clin Rev Allergy Immunol       Date:  2017-02       Impact factor: 8.667

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.